Gleason Score and Grade Groups: Prostate Cancer Grading for the USMLE

Prostate cancer is graded histologically by the Gleason system, in which a pathologist assigns two grades (1–5) based on the two most common architectural patterns; their sum is the Gleason score. To simplify interpretation, scores are collapsed into five Grade Groups that map onto rising risk categories. Higher scores and Grade Groups indicate more aggressive disease and drive treatment decisions.

How Gleason Grading Works

The pathologist assigns two Gleason grades (each 1–5) based on the two most common histologic patterns seen in the tumor. The Gleason score is the sum of these two grades (e.g., 3+4=7). A higher score reflects a more aggressive, poorly differentiated cancer. Because a score like 7 can arise from either 3+4 or 4+3 — with different prognoses — the order of the grades matters, which is why the Grade Group system was developed to add clarity.

Grade Group 1 — Gleason ≤6 (Low Risk)

A Gleason score of 6 or less corresponds to Grade Group 1 and carries low risk. These are the most indolent, well-differentiated cancers. Many of these low-risk tumors are candidates for active surveillance rather than immediate intervention, since the man is often more likely to die of another cause than of the prostate cancer itself.

Grade Group 2 — Gleason 3+4=7 (Favorable Intermediate Risk)

When the predominant pattern is grade 3 and the secondary pattern is grade 4 (3+4=7), the tumor is Grade Group 2, classified as favorable intermediate risk. The predominance of the lower-grade pattern makes this less aggressive than a 4+3=7, underscoring why grade order — not just the sum — determines risk.

Grade Group 3 — Gleason 4+3=7 (Unfavorable Intermediate Risk)

A Gleason 4+3=7 has grade 4 as the dominant pattern and is Grade Group 3, classified as unfavorable intermediate risk. Despite sharing the same numeric score (7) as Grade Group 2, this tumor behaves more aggressively because the higher-grade pattern predominates.

Grade Group 4 — Gleason 8 (High Risk)

A Gleason score of 8 corresponds to Grade Group 4 and is high risk. These are poorly differentiated cancers. Intermediate- and high-risk localized disease is managed with definitive therapy such as radical prostatectomy, external beam radiation (± androgen deprivation therapy), or brachytherapy.

Grade Group 5 — Gleason 9–10 (Very High Risk)

A Gleason score of 9 or 10 is Grade Group 5, the most aggressive category, carrying very high risk. These tumors are the most poorly differentiated and most likely to behave aggressively and metastasize.

High-yield

  • Gleason score = sum of the two most common architectural patterns, each graded 1–5.
  • Higher Gleason score = more aggressive, more poorly differentiated cancer.
  • Five Grade Groups map onto rising risk: 1 (low), 2 (favorable intermediate), 3 (unfavorable intermediate), 4 (high), 5 (very high).
  • Gleason ≤6 = Grade Group 1 = low risk; often managed with active surveillance.
  • 3+4=7 (Grade Group 2, favorable intermediate) is less aggressive than 4+3=7 (Grade Group 3, unfavorable intermediate) despite the identical score of 7.
  • Gleason 8 = Grade Group 4 = high risk; Gleason 9–10 = Grade Group 5 = very high risk.
  • Prostate cancer screening and management require shared decision-making; many low-risk cancers are better observed than treated.

Pitfalls

  • Assuming a Gleason 7 is a single entity — 3+4=7 and 4+3=7 fall into different Grade Groups (2 vs 3) with different risk.
  • Ignoring the order of the two grades; the dominant (first) pattern drives prognosis.
  • Equating Grade Group number directly with the Gleason score — Grade Group 1 corresponds to Gleason ≤6, not Gleason 1.
  • Reflexively treating every prostate cancer aggressively; low-risk (Grade Group 1) disease is often appropriate for active surveillance.
  • Confusing a higher Gleason score as better differentiation — it is the opposite; higher means more aggressive.

Clinical pearls

  • The Gleason score is the sum of the two most common patterns, so the minimum clinically reported score is effectively 6 (Grade Group 1).
  • When you see 4+3=7, think unfavorable intermediate risk (Grade Group 3) — the higher-grade pattern is dominant.
  • Grade Groups 1 through 5 climb neatly from low to very high risk — a clean framework for exam questions.
  • Low-risk Grade Group 1 disease may warrant active surveillance to spare men treatment side effects.

Frequently asked

How is the Gleason score calculated?

A pathologist assigns two grades (1–5) to the two most common histologic patterns in the tumor, and the Gleason score is their sum (e.g., 3+4=7). A higher score means a more aggressive cancer.

Why do 3+4=7 and 4+3=7 have different risk classifications?

Although both sum to 7, the order reflects which pattern predominates. 3+4=7 is dominated by the lower-grade pattern and is Grade Group 2 (favorable intermediate risk), whereas 4+3=7 is dominated by the higher-grade pattern and is Grade Group 3 (unfavorable intermediate risk).

What Gleason score corresponds to Grade Group 1?

A Gleason score of 6 or less is Grade Group 1, the lowest-risk category.

Which Grade Group is considered very high risk?

Grade Group 5, which corresponds to a Gleason score of 9 or 10 — the most aggressive, poorly differentiated tumors.

How does grading influence management of prostate cancer?

Low-risk disease (Grade Group 1) is often managed with active surveillance, while intermediate- and high-risk localized disease is treated with definitive therapy such as radical prostatectomy, external beam radiation ± androgen deprivation therapy, or brachytherapy.

Does a higher Gleason score mean better or worse differentiation?

Worse. A higher Gleason score reflects more poorly differentiated, more aggressive cancer.

What is the range of Grade Groups?

There are five Grade Groups, numbered 1 through 5, corresponding to increasing aggressiveness and risk: low, favorable intermediate, unfavorable intermediate, high, and very high.

Turn this into reasoning you can use on exam day — practice Gleason Score and Grade Groups on branching cases where your decisions shape the patient.